Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Nicole Massoll

Concepts (206)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Nodule
5
2022
31
1.200
 Why?
Thyroid Neoplasms
8
2022
110
1.160
 Why?
Biopsy, Fine-Needle
6
2020
103
0.580
 Why?
Cyclin-Dependent Kinase Inhibitor p16
2
2008
55
0.550
 Why?
Uterus
2
2008
94
0.540
 Why?
Papillomavirus Infections
2
2008
155
0.480
 Why?
Carcinoma, Papillary
3
2017
48
0.480
 Why?
Breast Neoplasms
6
2018
1174
0.390
 Why?
Vulvar Neoplasms
3
2008
52
0.370
 Why?
Carcinoma, Squamous Cell
4
2008
318
0.370
 Why?
Cysts
2
2006
51
0.340
 Why?
MicroRNAs
3
2022
353
0.330
 Why?
Uterine Cervical Neoplasms
2
2008
277
0.300
 Why?
Uterine Cervical Dysplasia
1
2008
49
0.300
 Why?
Precancerous Conditions
1
2008
83
0.300
 Why?
Carcinoma, Lobular
1
2007
33
0.280
 Why?
Cytological Techniques
1
2006
14
0.280
 Why?
Carcinoma, Ductal, Breast
1
2007
89
0.270
 Why?
Adenomyoma
1
2005
2
0.260
 Why?
Neoplasms, Hormone-Dependent
1
2005
8
0.260
 Why?
Carcinoma in Situ
2
2008
73
0.260
 Why?
Gynecologic Surgical Procedures
1
2005
30
0.250
 Why?
Focal Adhesion Protein-Tyrosine Kinases
3
2010
20
0.250
 Why?
Biopsy, Needle
1
2006
183
0.250
 Why?
Uterine Neoplasms
1
2005
60
0.250
 Why?
Lymph Nodes
3
2017
260
0.250
 Why?
Carcinoma, Medullary
1
2004
12
0.240
 Why?
Mastectomy
2
2018
140
0.210
 Why?
Humans
30
2022
49974
0.200
 Why?
Focal Adhesion Kinase 1
2
2012
15
0.190
 Why?
Female
20
2020
26472
0.180
 Why?
Diagnostic Tests, Routine
1
2020
29
0.180
 Why?
Carcinoma, Neuroendocrine
1
2020
24
0.180
 Why?
Diagnosis, Differential
4
2008
1037
0.180
 Why?
Mutation
6
2022
1294
0.180
 Why?
DNA, Neoplasm
2
2018
147
0.170
 Why?
Lung Neoplasms
2
2015
606
0.170
 Why?
Protein Kinase Inhibitors
2
2012
204
0.170
 Why?
Proto-Oncogene Proteins B-raf
2
2017
79
0.160
 Why?
Immunohistochemistry
6
2015
973
0.150
 Why?
Thyroid Gland
3
2020
73
0.150
 Why?
Pancreatic Neoplasms
2
2010
208
0.140
 Why?
Gene Silencing
2
2008
119
0.140
 Why?
Middle Aged
10
2020
12069
0.140
 Why?
Neoplasm Invasiveness
5
2015
267
0.140
 Why?
DNA, Viral
2
2008
133
0.130
 Why?
Pathology
2
2006
33
0.130
 Why?
PTEN Phosphohydrolase
1
2016
55
0.130
 Why?
Pulmonary Medicine
1
2015
15
0.130
 Why?
Fibroblasts
2
2016
345
0.130
 Why?
Cytodiagnosis
1
2015
42
0.130
 Why?
Sensitivity and Specificity
3
2020
861
0.120
 Why?
Cell Proliferation
4
2016
1007
0.120
 Why?
Endosonography
1
2015
92
0.120
 Why?
Adult
9
2020
13236
0.120
 Why?
Aged, 80 and over
5
2020
3129
0.120
 Why?
Lymphatic Metastasis
3
2017
224
0.120
 Why?
Receptor, erbB-2
2
2018
73
0.110
 Why?
Laryngeal Diseases
1
2013
12
0.110
 Why?
Herpes Simplex
1
2013
21
0.110
 Why?
Laryngectomy
1
2013
28
0.110
 Why?
Purine Nucleosides
1
2012
3
0.110
 Why?
Receptor, IGF Type 1
1
2012
20
0.110
 Why?
Immunoenzyme Techniques
2
2008
143
0.100
 Why?
Predictive Value of Tests
2
2020
903
0.090
 Why?
Receptors, Somatomedin
1
2010
8
0.090
 Why?
Vascular Endothelial Growth Factor Receptor-3
1
2009
5
0.090
 Why?
Tissue Fixation
2
2020
36
0.090
 Why?
Aniline Compounds
1
2009
43
0.080
 Why?
Retrospective Studies
5
2022
6108
0.080
 Why?
Melanoma
1
2012
285
0.080
 Why?
Fluorescent Antibody Technique, Direct
1
2008
3
0.080
 Why?
Cell Movement
1
2009
247
0.080
 Why?
Neuroblastoma
1
2008
52
0.080
 Why?
Aged
5
2020
9310
0.080
 Why?
Transglutaminases
1
2008
15
0.080
 Why?
Mastitis
1
2007
3
0.080
 Why?
Biopsy
2
2007
584
0.080
 Why?
Genetic Markers
1
2008
102
0.070
 Why?
GTP-Binding Proteins
1
2008
90
0.070
 Why?
Genes, erbB-2
1
2007
8
0.070
 Why?
Granuloma
1
2007
43
0.070
 Why?
Prednisone
1
2007
99
0.070
 Why?
Group Practice
1
2006
3
0.070
 Why?
Gene Expression Regulation, Enzymologic
1
2008
181
0.070
 Why?
Cystatins
1
2006
1
0.070
 Why?
Cadherins
1
2007
68
0.070
 Why?
Frozen Sections
1
2006
13
0.070
 Why?
Tumor Suppressor Protein p53
1
2008
202
0.070
 Why?
Specialization
1
2006
46
0.070
 Why?
Genomic Instability
1
2007
92
0.070
 Why?
Colonic Neoplasms
1
2008
161
0.070
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2008
595
0.070
 Why?
Medicine
1
2006
56
0.070
 Why?
RNA, Small Interfering
3
2012
215
0.070
 Why?
Mullerian Ducts
1
2005
4
0.070
 Why?
Promoter Regions, Genetic
1
2008
475
0.070
 Why?
Gene Expression
1
2008
609
0.070
 Why?
Antigens, CD
1
2007
219
0.070
 Why?
Fallopian Tubes
1
2005
22
0.070
 Why?
Medical Oncology
1
2006
94
0.060
 Why?
Signal Transduction
1
2012
1618
0.060
 Why?
Glucocorticoids
1
2007
219
0.060
 Why?
Vulva
1
2005
17
0.060
 Why?
ABO Blood-Group System
1
2005
15
0.060
 Why?
Data Collection
1
2006
279
0.060
 Why?
Estrogen Replacement Therapy
1
2005
41
0.060
 Why?
Chromosome Aberrations
1
2007
297
0.060
 Why?
Ovariectomy
1
2005
119
0.060
 Why?
Hysterectomy
1
2005
88
0.060
 Why?
Decision Making
1
2007
265
0.060
 Why?
Mice, Nude
3
2010
252
0.060
 Why?
Carcinoma, Transitional Cell
1
2005
52
0.060
 Why?
Regression Analysis
1
2006
395
0.060
 Why?
Epithelial Cells
1
2006
209
0.060
 Why?
Papillomaviridae
1
2005
102
0.060
 Why?
Epigenesis, Genetic
1
2008
374
0.060
 Why?
Cell Survival
3
2012
600
0.060
 Why?
Cell Line, Tumor
4
2009
1403
0.060
 Why?
Cohort Studies
2
2020
1422
0.060
 Why?
Mice
5
2017
5739
0.060
 Why?
Male
6
2020
25241
0.060
 Why?
Ultrasonography
1
2006
436
0.060
 Why?
Polymerase Chain Reaction
1
2005
453
0.060
 Why?
Prospective Studies
2
2022
2364
0.060
 Why?
Base Sequence
3
2010
643
0.060
 Why?
Gene Expression Profiling
1
2007
1032
0.050
 Why?
Formaldehyde
1
2020
52
0.050
 Why?
Oncogenes
1
2020
57
0.050
 Why?
Adolescent
2
2015
6356
0.040
 Why?
Neoplasm Staging
2
2015
740
0.040
 Why?
Transplantation, Heterologous
2
2010
74
0.040
 Why?
Antineoplastic Agents
1
2008
1171
0.040
 Why?
Animals
5
2017
13187
0.040
 Why?
Blotting, Western
2
2012
601
0.040
 Why?
DNA Primers
2
2010
207
0.040
 Why?
Young Adult
2
2020
3958
0.040
 Why?
Paraffin Embedding
1
2018
53
0.040
 Why?
Specimen Handling
1
2018
55
0.040
 Why?
Receptors, Progesterone
1
2018
63
0.040
 Why?
Receptors, Estrogen
1
2018
130
0.040
 Why?
Lymphatic System
1
2017
14
0.040
 Why?
Methylene Blue
1
2017
10
0.040
 Why?
Animals, Genetically Modified
1
2017
49
0.040
 Why?
Coloring Agents
1
2017
69
0.040
 Why?
Mice, Inbred Strains
1
2017
161
0.040
 Why?
Prognosis
2
2015
1942
0.040
 Why?
Follow-Up Studies
2
2015
2182
0.030
 Why?
Treatment Outcome
1
2006
5141
0.030
 Why?
Cost Savings
1
2015
58
0.030
 Why?
Apoptosis
2
2012
1101
0.030
 Why?
Neoplasm Grading
1
2015
123
0.030
 Why?
RNA, Messenger
2
2008
1105
0.030
 Why?
Collagen
1
2016
206
0.030
 Why?
Disease Progression
2
2008
825
0.030
 Why?
Cost-Benefit Analysis
1
2015
274
0.030
 Why?
Tumor Microenvironment
1
2016
212
0.030
 Why?
DNA Methylation
2
2008
548
0.030
 Why?
Immunoprecipitation
1
2012
59
0.030
 Why?
In Situ Nick-End Labeling
1
2012
57
0.030
 Why?
Flow Cytometry
1
2012
476
0.020
 Why?
Staurosporine
1
2009
12
0.020
 Why?
Cell Line
1
2012
1000
0.020
 Why?
Deoxycytidine
1
2009
27
0.020
 Why?
Drug Synergism
1
2009
150
0.020
 Why?
Cell Adhesion
1
2009
158
0.020
 Why?
Xenograft Model Antitumor Assays
1
2009
211
0.020
 Why?
RNA Interference
1
2009
179
0.020
 Why?
Polymorphism, Single-Stranded Conformational
1
2008
19
0.020
 Why?
Luciferases
1
2008
50
0.020
 Why?
Chromatin Immunoprecipitation
1
2008
49
0.020
 Why?
Adenoviridae
1
2008
51
0.020
 Why?
Florida
1
2008
58
0.020
 Why?
Fluorouracil
1
2008
54
0.020
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2008
67
0.020
 Why?
Loss of Heterozygosity
1
2008
77
0.020
 Why?
Electrophoresis, Polyacrylamide Gel
1
2008
102
0.020
 Why?
Phosphorylation
1
2009
535
0.020
 Why?
Transcriptional Activation
1
2008
121
0.020
 Why?
Estrogens
1
2009
227
0.020
 Why?
Drug Screening Assays, Antitumor
1
2008
136
0.020
 Why?
Transfection
1
2008
354
0.020
 Why?
Ultrasonography, Mammary
1
2007
60
0.020
 Why?
Enzyme Inhibitors
1
2009
391
0.020
 Why?
Kaplan-Meier Estimate
1
2008
466
0.020
 Why?
Cystatin M
1
2006
20
0.020
 Why?
Transcription, Genetic
1
2008
369
0.020
 Why?
5' Untranslated Regions
1
2006
31
0.020
 Why?
Molecular Sequence Data
1
2008
792
0.020
 Why?
RNA, Neoplasm
1
2006
44
0.020
 Why?
Cesarean Section
1
2007
187
0.020
 Why?
Survival Rate
1
2008
894
0.020
 Why?
Mice, Knockout
1
2008
841
0.020
 Why?
Gene Expression Regulation, Neoplastic
1
2009
828
0.020
 Why?
Chi-Square Distribution
1
2005
280
0.010
 Why?
Cells, Cultured
1
2008
1573
0.010
 Why?
Neoplasm Recurrence, Local
1
2008
614
0.010
 Why?
Pregnancy Complications
1
2007
382
0.010
 Why?
Tomography, X-Ray Computed
1
2007
1159
0.010
 Why?
Infant, Newborn
1
2008
2772
0.010
 Why?
Magnetic Resonance Imaging
1
2007
1537
0.010
 Why?
Pregnancy
1
2007
2607
0.010
 Why?
Infant
1
2008
3567
0.010
 Why?
Risk Factors
1
2008
3613
0.010
 Why?
Child, Preschool
1
2008
3871
0.010
 Why?
Child
1
2008
6847
0.010
 Why?
Massoll's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (206) concept(s)
_
Co-Authors Expand Description
See all (8) people
_
Similar People Expand Description
See all (38) people
_
Same Department Expand Description
Search Department